Get the Stockscreener App
0.2585
1.17%
0.003
Renovaro Inc stock is traded at $0.2585, with a volume of 570.52K.
It is up +1.17% in the last 24 hours and down -4.96% over the past month.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.2555
Open:
$0.27
24h Volume:
570.52K
Relative Volume:
0.17
Market Cap:
$44.49M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.3693
EPS:
-0.7
Net Cash Flow:
$-11.54M
1W Performance:
-16.32%
1M Performance:
-4.96%
6M Performance:
-65.53%
1Y Performance:
-63.08%
1-Day Range:
$0.2506
$0.27
1-Week Range:
$0.2506
$0.35
52-Week Range:
$0.2506
$2.10
Renovaro Inc Stock (RENB) Company Profile
Name
Renovaro Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.2585 | 57.67M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Stock (RENB) Latest News
How strong is Renovaro Inc. company’s balance sheetFree Stock Review For Consistent Profits - jammulinksnews.com
What are analysts’ price targets for Renovaro Inc. in the next 12 monthsStock Market Data Feed For Consistent Profits - jammulinksnews.com
How does Renovaro Inc. compare to its industry peersDaily Trading Ideas For Fast Growth - jammulinksnews.com
When is Renovaro Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - jammulinksnews.com
What are Renovaro Inc. company’s key revenue driversDaily Trading Tracker For Fast Growth - jammulinksnews.com
Why Renovaro Inc. stock attracts strong analyst attentionSwing Trading Entry Signals Suggest Opportunity Zone - beatles.ru
Candlestick Reversal Detected on Renovaro Inc.’s ChartWeekly Watchlist of High Movers Released - metal.it
AI Just Got a Green Light from the White House–Here’s What That Means for Healthcare Stocks - Cantech Letter
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks - PR Newswire Canada
Is This a Bottoming Phase for Renovaro Inc.Wealth Building Stock Market Ideas Based on Momentum - beatles.ru
Is it the right time to buy Renovaro Inc. stockCapitalize on market opportunities with confidence - jammulinksnews.com
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Trading Bots Trigger Alerts on Renovaro Inc. ActivityReal Profit Trade Plan Suggestions Shared Widely - metal.it
Should I hold or sell Renovaro Inc. stock in 2025Daily Trading Review That Work - jammulinksnews.com
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - USA Today
Elliott Wave Theory Predicts Pullback in Renovaro Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Renovaro BioSciences secures multiple U.S. patents in biomedical AI - TipRanks
Renovaro (RENB) Fortifies Position with New U.S. Patent Approvals - GuruFocus
Renovaro Multiple U.S. Patent Allowances To Bolster Biomedical AI Platform, Including Application No. 18/058,732 For Unbiased Drug Discovery Predictions - 富途牛牛
What are the latest earnings results for Renovaro Inc.Free Market Dynamics Reports - jammulinksnews.com
What makes Renovaro Inc. stock price move sharplyDiscover high-impact stocks for your portfolio - jammulinksnews.com
What institutional investors are buying Renovaro Inc. stockBuild wealth steadily with proven stock picks - jammulinksnews.com
Is Renovaro Inc. stock overvalued or undervaluedDiscover investment plans that deliver results - jammulinksnews.com
Competitive Positioning of Renovaro Inc.: Is It Leading or LaggingShort Term Profit Focus - metal.it
What are the technical indicators suggesting about Renovaro Inc.Capitalize on market trends before they peak - jammulinksnews.com
How many analysts rate Renovaro Inc. as a “Buy”Maximize portfolio growth with professional advice - jammulinksnews.com
Renovaro chairman Maurice van Tilburg to step down in August - Investing.com Australia
Is Renovaro Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia
Renovaro Biosciences Chairman Announces Resignation - TipRanks
Renovaro Inc. Stock Analysis and ForecastHigh-profit capital plays - PrintWeekIndia
What drives Renovaro Inc. stock priceJaw-dropping returns - Autocar Professional
What analysts say about Renovaro Inc. stockTremendous portfolio expansion - Autocar Professional
How high can Renovaro Inc. stock price go in 2025Tremendous return rates - jammulinksnews.com
Renovaro Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):